Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

6

Number of overlapping holdings

20.0%

% of MEDX's 30 holdings also in XPH

15.0%

% of XPH's 40 holdings also in MEDX

Overlap by Weight
Sector Drift (MEDX minus XPH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in MEDX
Weight
in XPH
Overlap
ELI LILLY & CO 18.6% 4.3% 4.3%
JOHNSON & JOHNSON 5.3% 4.1% 4.1%
PFIZER INC 3.8% 3.7% 3.7%
BRISTOL-MYERS SQUIBB CO 5.8% 3.5% 3.5%
MERCK & CO. INC. 3.5% 3.6% 3.5%

Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to XPH
ELI LILLY & CO 14.3%
ABBVIE INC 8.8%
NOVARTIS AG-ADR 7.0%
AMGEN INC 6.2%
ASTRAZENECA PLC-SPONS ADR 5.6%
ALNYLAM PHARMACEUTICALS INC 4.5%
ALKERMES PLC 4.1%
REGENERON PHARMACEUTICALS 2.7%
GLAXOSMITHKLINE PLC-SPON ADR 2.7%
CRISPR THERAPEUTICS AG 2.6%
MEDX Underweight Relative to XPH
CORCEPT THERAPEUTICS INC -4.8%
TARSUS PHARMACEUTICALS, INC. -4.2%
ROYALTY PHARMA PLC CLASS A -4.2%
PERRIGO CO -3.9%
ZOETIS INC -3.9%
PRESTIGE BRANDS HOLDINGS INC -3.9%
AXSOME THERAPEUTICS, INC. -3.7%
ELANCO ANIMAL HEALTH, INC. -3.5%
VIATRIS, INC. -3.3%
JAZZ PHARMACEUTICALS PLC -3.3%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY